Felbamate add-on therapy for drug-resistant focal epilepsy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Felbamate add-on therapy for drug-resistant focal epilepsy

Published:2022-08-01 Issue:8 Volume:2022 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Shi Li Li¹,Bresnahan Rebecca²,Martin-McGill Kirsty J³,Dong JianCheng⁴,Ni HengJian⁴,Geng JinSong⁴

Affiliation:

1. Evidence-based Medicine Center, Medical School of Nantong University; Nantong China

2. Department of Health Data Science; Institute of Population Health, University of Liverpool; Liverpool UK

3. The Centre for Advancing Practice; Health Education England; Chester UK

4. Evidence-based Medicine Center; Medical School of Nantong University; Nantong China

Publisher

Wiley

Subject

Pharmacology (medical)

Reference33 articles.

1. Felbamate as add-on therapy in adult patients with partial drug-resistant epilepsy;Binelli;Bollettino - Lega Italiana Contro L'Epilessia,1999

2. Felbamate: a double-blind controlled trial in patients undergoing presurgical evaluation of partial seizures;Bourgeois;Neurology,1993

3. Felbamate for partial seizures: results of a controlled clinical trial;Leppik;Neurology,1991

4. Felbamate: a clinical trial for complex partial seizures;Theodore;Epilepsia,1991

5. Felbamate as add-on therapy;Li;European Neurology,1996

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP